Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Bachem expands multi-site production capacities to meet rising demand
Thursday, May 22, 2025Bachem has announced major investment across their site network with new funding to improve production facilities at their Bubendorf Vista and St Helens sites along with a new site in Sisseln The expansion plans come in response to the growing demand...
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
Wednesday, May 21, 2025Basilea Pharmaceutica Ltd Allschwil a commercialstage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections announced today that its antibiotic Zevtera ceftobiprole medocaril for injection is...
Philikos announces initiation of clinical Phase 1/2 study with T-Guard® in patients with systemic sclerosis
Wednesday, May 21, 2025Philikos BV a Dutch biotechnology company developing antibodybased therapies to treat severe immune disorders today announced that it has enrolled the first patient in a Phase clinical trial designed to evaluate the use of TGuard
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
Tuesday, May 20, 2025CRISPR Therapeutics a biopharmaceutical company focused on creating transformative genebased medicines for serious diseases and Sirius Therapeutics a clinical stage biotech company developing innovative small interfering RNA siRNA
Basil Systems Launches AI-Powered Insights Tool to Accelerate Pharma Labeling Strategy and Market Intelligence
Tuesday, May 20, 2025Basil Systems the leading AIpowered product lifecycle intelligence platform for the life sciences industry today announced the launch of Insights a powerful new feature within its Basil Intel for Pharma platform
Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery
Saturday, May 17, 2025Artificial intelligence has rapidly evolved from academic theory into a transformative force in pharmaceutical RD From early QSAR models to neural networks and now to AlphaFold AI has progressively unlocked deeper biological insights
IMU Biosciences Adopts Curiox's Pluto for Large-Scale UK Immune Profiling Initiative
Friday, May 16, 2025Curiox Biosystems Co Ltd Curiox announced on March that it has officially received a Sales Order for its Pluto Workstation Pluto from IMU Biosciences IMU a UK based techbio company decoding the immune system
Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy
Friday, May 16, 2025Aldevron a global leader in the production of DNA RNA and protein together with Integrated DNA Technologies IDT a global leader in genomics solutions announced the successful manufacture of the worlds first personalized CRISPR gene editing drug produ...
Ryvu Therapeutics to Present Clinical and Preclinical Data on RVU120 at the European Hematology Association Congress 2025 in June
Thursday, May 15, 2025Ryvu Therapeutics a clinicalstage drug discovery and development company focusing on novel therapies that address emerging targets in oncology today announced it will present RVU data including one oral presentation and four poster presentations
Roche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with Emrelis
Thursday, May 15, 2025Roche announced today that the FDA has approved the VENTANA MET SP RxDx Assay the first companion diagnostic approved to aid in determining MET also known as cMet protein expression in NSQNSCLC patients
